Peptides in the Limelight: US FDA May Ease Restrictions on Several Peptides The Dermatology Digest BPC 157 Explained: Benefits, Safety & Oral vs Injectable Options FDA's Overreach on Compounded Peptides Which non FDA (United States Food and Drug Administration) approved peptides, such as BPC 157 (Body Protection Compound 157) and TB 500 (Thymosin Beta 500), are likely legitimate for medical use under strict supervision? Early evidence suggests BPC 157 repairs tissue rather than just dulling symptoms. To read more, tap the link in bio. When will the FDA reclassify BPC 157 to Category 1? Odds & Predictions